Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Manhattan Associates Inc (MANH) Price & Performance

Abeona Therapeutics IncTrade
Manhattan Associates IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Manhattan Associates Inc — how do they compare? Abeona Therapeutics Inc trades at $7.37 (market cap $421.19M), while Manhattan Associates Inc trades at $189.84 (market cap $11.38B). The key difference: Manhattan Associates Inc is far larger — about 27× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Manhattan Associates Inc nearer its low. Which is the better fit depends on your goals.

ABEOMANH
Market Cap
$421.19M$11.38B
Sector
HealthTechnology
52-Week High
$7.45$220.19
52-Week Low
$4.17$120.88
Enterprise Value
$276.10M$11.25B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Manhattan Associates Inc

Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.

Read more on MANH